Glenmark launches Ryaltris-AZ nasal spray for treatment of allergic rhinitis; Stock surges 1%

Glenmark is the first company in the world to launch Ryaltris-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg.

from India Infoline News Service https://ift.tt/3eSc7LW